VP26B_HUMAN - dbPTM
VP26B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID VP26B_HUMAN
UniProt AC Q4G0F5
Protein Name Vacuolar protein sorting-associated protein 26B
Gene Name VPS26B
Organism Homo sapiens (Human).
Sequence Length 336
Subcellular Localization Cytoplasm . Membrane
Peripheral membrane protein . Early endosome . Late endosome . Localizes to early and late endosomal structures (By similarity).
Protein Description Acts as component of the retromer cargo-selective complex (CSC). The CSC is believed to be the core functional component of retromer or respective retromer complex variants acting to prevent missorting of selected transmembrane cargo proteins into the lysosomal degradation pathway. The recruitment of the CSC to the endosomal membrane involves RAB7A and SNX3. The SNX-BAR retromer mediates retrograde transport of cargo proteins from endosomes to the trans-Golgi network (TGN) and is involved in endosome-to-plasma membrane transport for cargo protein recycling. The SNX3-retromer mediates the retrograde transport of WLS distinct from the SNX-BAR retromer pathway. The SNX27-retromer is believed to be involved in endosome-to-plasma membrane trafficking and recycling of a broad spectrum of cargo proteins. The CSC seems to act as recruitment hub for other proteins, such as the WASH complex and TBC1D5. May be involved in retrograde transport of SORT1 but not of IGF2R. Acts redundantly with VSP26A in SNX-27 mediated endocytic recycling of SLC2A1/GLUT1 (By similarity)..
Protein Sequence MSFFGFGQSVEVEILLNDAESRKRAEHKTEDGKKEKYFLFYDGETVSGKVSLALKNPNKRLEHQGIKIEFIGQIELYYDRGNHHEFVSLVKDLARPGEITQSQAFDFEFTHVEKPYESYTGQNVKLRYFLRATISRRLNDVVKEMDIVVHTLSTYPELNSSIKMEVGIEDCLHIEFEYNKSKYHLKDVIVGKIYFLLVRIKIKHMEIDIIKRETTGTGPNVYHENDTIAKYEIMDGAPVRGESIPIRLFLAGYELTPTMRDINKKFSVRYYLNLVLIDEEERRYFKQQEVVLWRKGDIVRKSMSHQAAIASQRFEGTTSLGEVRTPSQLSDNNCRQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSFFGFGQS
------CCCCCCCCE
29.3224043423
9PhosphorylationSFFGFGQSVEVEILL
CCCCCCCEEEEEEEE
22.1824043423
21PhosphorylationILLNDAESRKRAEHK
EEECCHHHHHHHCCC
44.8424043423
55UbiquitinationGKVSLALKNPNKRLE
EEEEEEECCCCCCCE
65.83-
1862-HydroxyisobutyrylationNKSKYHLKDVIVGKI
CCCCCCHHHHHHHHH
36.32-
186UbiquitinationNKSKYHLKDVIVGKI
CCCCCCHHHHHHHHH
36.32-
203AcetylationLLVRIKIKHMEIDII
HHHHHCCCCCEEEEE
31.7111925337
211UbiquitinationHMEIDIIKRETTGTG
CCEEEEEEEECCCCC
44.51-
231PhosphorylationENDTIAKYEIMDGAP
CCCCEEEEEEECCCC
11.1525954137
243PhosphorylationGAPVRGESIPIRLFL
CCCCCCCCCCEEEEE
36.1724719451
258PhosphorylationAGYELTPTMRDINKK
CCEECCCCHHHHHHH
21.43-
301UbiquitinationRKGDIVRKSMSHQAA
ECCHHHHHHHCHHHH
39.35-
302PhosphorylationKGDIVRKSMSHQAAI
CCHHHHHHHCHHHHH
18.2330266825
303SulfoxidationGDIVRKSMSHQAAIA
CHHHHHHHCHHHHHH
4.6830846556
304PhosphorylationDIVRKSMSHQAAIAS
HHHHHHHCHHHHHHH
21.3823927012
311PhosphorylationSHQAAIASQRFEGTT
CHHHHHHHHCCCCCC
18.7717525332
317PhosphorylationASQRFEGTTSLGEVR
HHHCCCCCCCCCEEC
13.1529255136
318PhosphorylationSQRFEGTTSLGEVRT
HHCCCCCCCCCEECC
32.5829255136
319PhosphorylationQRFEGTTSLGEVRTP
HCCCCCCCCCEECCH
33.9323401153
325PhosphorylationTSLGEVRTPSQLSDN
CCCCEECCHHHCCCC
32.2529255136
327PhosphorylationLGEVRTPSQLSDNNC
CCEECCHHHCCCCCC
43.0429255136
330PhosphorylationVRTPSQLSDNNCRQ-
ECCHHHCCCCCCCC-
30.5619413330

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of VP26B_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of VP26B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of VP26B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
VPS35_HUMANVPS35physical
22939629
VPS29_HUMANVPS29physical
22939629
VPS29_HUMANVPS29physical
26186194
VPS35_HUMANVPS35physical
26186194
NEK1_HUMANNEK1physical
26186194
SPT5H_HUMANSUPT5Hphysical
26186194
ATE1_HUMANATE1physical
26186194
TBCD5_HUMANTBC1D5physical
26186194
CU002_HUMANC21orf2physical
26186194
BTBD9_HUMANBTBD9physical
26186194
SNX27_HUMANSNX27physical
26186194
VPS29_HUMANVPS29physical
26344197
VPS35_HUMANVPS35physical
26344197
ABCD1_HUMANABCD1physical
26496610
CO4A5_HUMANCOL4A5physical
26496610
ETV6_HUMANETV6physical
26496610
KIF5A_HUMANKIF5Aphysical
26496610
MYH1_HUMANMYH1physical
26496610
TTF1_HUMANTTF1physical
26496610
TBCD5_HUMANTBC1D5physical
26496610
WASC5_HUMANKIAA0196physical
26496610
SDCG3_HUMANSDCCAG3physical
26496610
RT30_HUMANMRPS30physical
26496610
MYCB2_HUMANMYCBP2physical
26496610
KIF1B_HUMANKIF1Bphysical
26496610
FKB15_HUMANFKBP15physical
26496610
WASC4_HUMANKIAA1033physical
26496610
PPIL2_HUMANPPIL2physical
26496610
MTO1_HUMANMTO1physical
26496610
TXD11_HUMANTXNDC11physical
26496610
VPS29_HUMANVPS29physical
26496610
VPS35_HUMANVPS35physical
26496610
SNX16_HUMANSNX16physical
26496610
C102B_HUMANCCDC102Bphysical
26496610
CHD9_HUMANCHD9physical
26496610
ACTL8_HUMANACTL8physical
26496610
TRIM7_HUMANTRIM7physical
26496610
ANR27_HUMANANKRD27physical
26496610
C102A_HUMANCCDC102Aphysical
26496610
WAC2A_HUMANFAM21Aphysical
26496610
VPS29_HUMANVPS29physical
28514442
TBCD5_HUMANTBC1D5physical
28514442
NEK1_HUMANNEK1physical
28514442
VPS35_HUMANVPS35physical
28514442
SNX27_HUMANSNX27physical
28514442
CU002_HUMANC21orf2physical
28514442
ATE1_HUMANATE1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of VP26B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304 AND SER-319, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-327 AND SER-330, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311, AND MASSSPECTROMETRY.

TOP